NCT00241618View on ClinicalTrials.gov

Timing and Duration of Acute Hepatitis C Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 31, 2002

Study Completion Date

January 31, 2006

Conditions
Hepatitis C
Interventions
DRUG

Pegylated interferon alpha 2

DRUG

Ribavirin

Trial Locations (3)

11351

ASU Specialized Hospital, Cairo

Shebin Liver Center, Cairo

03316

ASU, Cairo

All Listed Sponsors
collaborator

University Hospital Freiburg

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Alexander von Humboldt Association

OTHER

collaborator

Fulbright

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

Tempus AI

INDUSTRY

collaborator

International Society for Infectious Diseases

OTHER

lead

Ain Shams University

OTHER

NCT00241618 - Timing and Duration of Acute Hepatitis C Treatment | Biotech Hunter | Biotech Hunter